Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Seth Wander"'
Autor:
Aditya Bardia, Daniel A. Haber, Shyamala Maheswaran, Leif W. Ellisen, Lee Zou, Gad Getz, A. John Iafrate, Mehmet Toner, Richard Lanman, Jerry Younger, Kristen Shannon, Beverly Moy, Laura Spring, Seth Wander, Douglas Micalizzi, Dejan Juric, Steven J. Isakoff, Jochen Lennerz, Giuliana Malvarosa, Brittany A. Reeves, Brian Chirn, Whijae Roh, Becky Nagy, Erica Blouch, Andrzej Niemierko, Antoine Simoneau, Michael S. Lawrence, Taronish Dubash, Neelima Vidula
Supplemental tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f8f984938202d81f8bb40c208e5d2c
https://doi.org/10.1158/1078-0432.22475513.v1
https://doi.org/10.1158/1078-0432.22475513.v1
Autor:
Aditya Bardia, Daniel A. Haber, Shyamala Maheswaran, Leif W. Ellisen, Lee Zou, Gad Getz, A. John Iafrate, Mehmet Toner, Richard Lanman, Jerry Younger, Kristen Shannon, Beverly Moy, Laura Spring, Seth Wander, Douglas Micalizzi, Dejan Juric, Steven J. Isakoff, Jochen Lennerz, Giuliana Malvarosa, Brittany A. Reeves, Brian Chirn, Whijae Roh, Becky Nagy, Erica Blouch, Andrzej Niemierko, Antoine Simoneau, Michael S. Lawrence, Taronish Dubash, Neelima Vidula
MAF of mutations detected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72583bc3e796f5a9e2176808caf364a0
https://doi.org/10.1158/1078-0432.22475516.v1
https://doi.org/10.1158/1078-0432.22475516.v1
Autor:
Aditya Bardia, Daniel A. Haber, Shyamala Maheswaran, Leif W. Ellisen, Lee Zou, Gad Getz, A. John Iafrate, Mehmet Toner, Richard Lanman, Jerry Younger, Kristen Shannon, Beverly Moy, Laura Spring, Seth Wander, Douglas Micalizzi, Dejan Juric, Steven J. Isakoff, Jochen Lennerz, Giuliana Malvarosa, Brittany A. Reeves, Brian Chirn, Whijae Roh, Becky Nagy, Erica Blouch, Andrzej Niemierko, Antoine Simoneau, Michael S. Lawrence, Taronish Dubash, Neelima Vidula
Survival curves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7901c482f7b586ee7e44ae692c216139
https://doi.org/10.1158/1078-0432.22475519
https://doi.org/10.1158/1078-0432.22475519
Autor:
Aditya Bardia, Daniel A. Haber, Shyamala Maheswaran, Leif W. Ellisen, Lee Zou, Gad Getz, A. John Iafrate, Mehmet Toner, Richard Lanman, Jerry Younger, Kristen Shannon, Beverly Moy, Laura Spring, Seth Wander, Douglas Micalizzi, Dejan Juric, Steven J. Isakoff, Jochen Lennerz, Giuliana Malvarosa, Brittany A. Reeves, Brian Chirn, Whijae Roh, Becky Nagy, Erica Blouch, Andrzej Niemierko, Antoine Simoneau, Michael S. Lawrence, Taronish Dubash, Neelima Vidula
Purpose:Plasma genotyping may identify mutations in potentially “actionable” cancer genes, such as BRCA1/2, but their clinical significance is not well-defined. We evaluated the characteristics of somatically acquired BRCA1/2 mutations in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de6651dc5f0aa1146000bd1122a6671
https://doi.org/10.1158/1078-0432.c.6529094.v1
https://doi.org/10.1158/1078-0432.c.6529094.v1
Autor:
Elizabeth K. O'Donnell, Yael N. Shapiro, Amy Comander, Steven J. Isakoff, Beverly Moy, Laura Spring, Seth Wander, Irene Kuter, Jennifer Shin, Jerry Younger, Michelle Specht, Chryssanthi Kourniotis, Carol Sullivan, Loren Winters, Nora Horick, Jeffrey Peppercorn
Publikováno v:
Cancer Research. 82:PD5-11
Background: Prior, retrospective analysis of nightly fasting among women with breast cancer suggests that fasting less than 13 hours per night may be associated with higher risk of breast cancer recurrence. Small studies suggest that fasting duration
Autor:
Mafalda Oliveira, Aditya Bardia, Sung-Bae Kim, Naoki Niikura, Cristina Hernando, Gustavo Werutsky, Yoland Antill, Pedro Liedke, Catherine Oakman, Eriko Tokunaga, Seth Wander, Vanessa Krause, Toshinari Yamashita, Frauke Schimmoller, Jacob Rotmensch, Heidi Savage, Rucha Sane, Nicholas Turner
Publikováno v:
Cancer Research. 82:P5-16
Background: Ipat is a potent oral AKT inhibitor that has been studied in multiple clinical trials, primarily in breast and prostate cancers. Combining fulv and AKT inhibition demonstrated efficacy in pts with HR+ aBC regardless of PI3K/AKT pathway al
Autor:
Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic, Katherine Clifton, Whitney L Hensing, Ami N Shah, Charles S Dai, Carolina Reduzzi, Paolo D’Amico, Qiang Zhang, Firas Wehbe, Seth Wander, William J Gradishar, Amir Behdad, Fabio Puglisi, Cynthia X Ma, Aditya Bardia, Massimo Cristofanilli
Publikováno v:
Cancer Research. 82:PD6-08
Background: High throughput genomic technologies such as NGS are enhancing the ability to dynamically characterize MBC but their role in describing biological evolution of multiple mutations together remains unclear. ESR1 and PIK3CA are central mutat
Autor:
Elizabeth O’Donnell, Yael Shapiro, Amy Comander, Steven Isakoff, Beverly Moy, Laura Spring, Seth Wander, Irene Kuter, Jennifer Shin, Michelle Specht, Chryssanthi Kournioti, Bonnie Hu, Carol Sullivan, Loren Winters, Nora Horick, Jeffrey Peppercorn
Publikováno v:
Breast cancer research and treatment. 193(3)
Retrospective analysis of nightly fasting among women with breast cancer suggests that fasting 13 h may be associated with a higher risk of breast cancer recurrence. We sought to evaluate prolonged overnight fasting (POF), an accessible nonpharmacolo
Autor:
Aditya Bardia, James T. Coates, Laura Spring, Sheng Sun, Dejan Juric, Nayana Thimmiah, Andrzej Niemierko, Phoebe Ryan, Ann Partridge, Jeffrey Peppercorn, Heather Parsons, Seth Wander, Kelsey Pierce, Victoria Attaya, Donna Fitzgerald, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Bev Moy, Sara Tolaney, Leif Ellisen
Publikováno v:
Cancer Research. 82:2638-2638
Background: Sacituzumab Govitecan (SG), the first antibody-drug conjugate approved for metastatic TNBC (mTNBC), is comprised of SN-38 (active metabolite of irinotecan), a topoisomerase I (TOP1) inhibitor, coupled via a hydrolyzable linker to monoclon
Autor:
Neelima, Vidula, Taronish, Dubash, Michael S, Lawrence, Antoine, Simoneau, Andrzej, Niemierko, Erica, Blouch, Becky, Nagy, Whijae, Roh, Brian, Chirn, Brittany A, Reeves, Giuliana, Malvarosa, Jochen, Lennerz, Steven J, Isakoff, Dejan, Juric, Douglas, Micalizzi, Seth, Wander, Laura, Spring, Beverly, Moy, Kristen, Shannon, Jerry, Younger, Richard, Lanman, Mehmet, Toner, A John, Iafrate, Gad, Getz, Lee, Zou, Leif W, Ellisen, Shyamala, Maheswaran, Daniel A, Haber, Aditya, Bardia
Publikováno v:
Clin Cancer Res
PURPOSE: Plasma genotyping may identify mutations in potentially “actionable” cancer genes, such as BRCA1/2, but their clinical significance is not well defined. We evaluated the characteristics of somatically acquired BRCA1/2 mutations in patien